Post-resection therapy in patients with metastatic colorectal Cancer (PORT) AIO KRK01418
Subject Area
Hematology, Oncology
General and Visceral Surgery
Term
since 2021
Project identifier
Deutsche Forschungsgemeinschaft (DFG) - Project number 427928818
The PORT (FIRE9) trials aims to establish additive/adjuvant therapy after definitive treatment of metastatic colorectal cancer. Currently the standard of care in the national guidelines is "structured follow-up". The hypothesis of the trial is a clinically relevant improvement of progression-free survival by the addition of 6 months systemic chemotherapy. Secondary endpoints of the trial include overall survival, quality of life, toxcity, efficacy in molecular subgroups and further translational work-up.
DFG Programme
Clinical Trials
